pH‐Responsive, Self‐Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death
Small · 2024
DOI: 10.1002/smll.202310636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Yu Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, Beijing, 100069, P. R. China. Hauptthemen laut MEDLINE: Ruthenium, Immunogenic Cell Death, Lysosomes, DNA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Research and Development Laboratory of Innovative Drugs for Metabolic Diseases of the Capital Medical University, Beijing Municipal Commission of Education.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Several DNA‐damaging antitumor agents, including ruthenium complexes, induce immunogenic cell death (ICD). In this study, an arginyl‐glycyl‐aspartic acid (RGD) peptide‐modified carboline ruthenium complex (KS‐Ru) is synthesized as a chemotherapeutic nanodrug and an ICD inducer. The RGD peptide, an integrin ligand, provides tumor‐specific targeting and promotes self‐assembly of the KS‐Ru complex. The pH‐responsive self‐assembly is assessed through transmission and scanning electron microscopy. Additionally, in vitro cytotoxic activity and anti‐metastasis ability are evaluated using MTT and Transwell assays, respectively, along with cellular immunofluorescence staining and imaging flow cytometry. The ability of the complex to inhibit primary tumor formation and lung metastasis in vivo is evaluated using Lewis lung cancer and A549 xenograft models. Furthermore, the tumor immune microenvironment is evaluated using single‐cell flow mass cytometry. KS‐Ru translocates to the nucleus, causing DNA damage and inducing ICD. Within the lysosomes, KS‐Ru self‐assembled into nanoflowers, leading to lysosomal swelling and apoptosis. Notably, the as‐synthesized pH‐dependent ruthenium nanomedicine achieves dual functionality—chemotherapy and immunotherapy. Moreover, the pH‐responsive self‐assembly of KS‐Ru enables simultaneous mechanisms in the lysosome and nucleus, thereby lowering the likelihood of drug resistance. This study provides valuable insight for the design of novel ruthenium‐based nanoantitumor drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, Beijing, 100069, P. R. China.
- Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, Laboratory for Cl…
- Department of Core Facility Center, Capital Medical University, Beijing, 100069, P. R. China.
- Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, P. R. China.
- Xuanwu Hospital, Capital Medical University, Beijing, 100053, P. R. China.
Förderung
- Research and Development Laboratory of Innovative Drugs for Metabolic Diseases of the Capital Medical University
- Beijing Municipal Commission of Education
Zitieren
APA
Lu, Y., Zhu, D., Hu, B., Chen, R., Wang, X., Xu, X., Wang, W., Wu, H., & Wang, Y. (2024). pH‐Responsive, Self‐Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death. Small. https://doi.org/10.1002/smll.202310636
Vancouver
Lu Y, Zhu D, Hu B, Chen R, Wang X, Xu X, et al. pH‐Responsive, Self‐Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death. Small. 2024. doi:10.1002/smll.202310636
BibTeX
@article{Lu2024,
author = {Lu, Yu and Zhu, Di and Hu, Bo and Chen, Rong and Wang, Xin and Xu, Xiaoxue and Wang, Wenjing and Wu, Hao and Wang, Yuji},
title = {pH‐Responsive, Self‐Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202310636}
}
EUVIMED